loader image
+39 089 233463 |info@ebris.eu

metabolomic

Optimizing and Predicting Antidepressant Efficacy in Patients with Major Depressive Disorder Using Multi-Omics Analysis and the Opade AI Prediction Tools

Abstract According to the World Health Organization (WHO), major depressive disorder (MDD) is the fourth leading cause of disability worldwide and the second most common [...]

2024-08-08T09:45:56+02:00Giugno 28th, 2024|Pubblicazioni|
Continua a leggere

Altered lung tissue lipidomic profile in caspase-4 positive non-small cell lung cancer (NSCLC) patients

Abstract Lung cancer is by far the leading cause of cancer death. Metabolomic studies have highlighted that both tumor progression and limited curative treatment options [...]

2021-04-26T12:42:36+02:00Ottobre 22nd, 2020|Pubblicazioni|
Continua a leggere

Altered lung tissue lipidomic profile in caspase-4 positive non-small cell lung cancer (NSCLC) patients

Lung cancer is by far the leading cause of cancer death. Metabolomic studies have highlighted that both tumor progression and limited curative treatment options are [...]

2020-12-11T12:47:59+01:00Settembre 22nd, 2020|Pubblicazioni|
Continua a leggere
Torna in cima